Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Regulus Therapeutics Inc.
Goto 0, 1, 2, 3, 4, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-03-01
Purchase
2022-03-01
5:58 pm
Regulus Therapeutics Inc.RGLSDrygin Denis
Chief Scientific Officer
76,686$0.23$17,638100,000
(Direct)
View
2022-02-04
Purchase
2022-02-07
5:09 pm
Regulus Therapeutics Inc.RGLSDrygin Denis
Chief Scientific Officer
23,314$0.23$5,36223,314
(Direct)
View
2022-01-12
Purchase
2022-01-26
4:13 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
100,000$0.2152$21,5202,017,006
(Direct)
View
2021-05-17
Sale
2021-05-17
7:13 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,186$0.89$3,726316,292
(Direct)
View
2021-05-17
Sale
2021-05-17
7:12 pm
Regulus Therapeutics Inc.RGLSAker Christopher Ray
Sr. VP & General Counsel
860$0.89$76541,754
(Direct)
View
2021-02-16
Sale(A)
2021-04-16
4:11 pm
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
4,144$1.72$7,128244,628
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-01-11(A)
Option Award
2023-01-17
4:13 pm
N/A
2033-01-10
Regulus Therapeutics Inc.RGLSAker Christopher Ray
Sr. VP & General Counsel
45,000$045,000
(Direct)
View
2023-01-11
Option Award
2023-01-17
4:11 pm
N/A
2033-01-10
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
100,000$0100,000
(Direct)
View
2023-01-11
Option Award
2023-01-17
4:10 pm
N/A
2033-01-10
Regulus Therapeutics Inc.RGLSCALSADA CRISPINA
Chief Financial Officer
45,000$045,000
(Direct)
View
2023-01-11
Option Award
2023-01-17
4:07 pm
N/A
2033-01-10
Regulus Therapeutics Inc.RGLSAker Christopher Ray
Sr. VP & General Counsel
30,000$030,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:24 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSCollier Kathryn J
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:21 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSBALTIMORE DAVID
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:19 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSHuang Alice Shih-hou
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:19 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSNunn Jason Raleigh
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:18 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSPAPADOPOULOS STELIOS
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:17 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSRASTETTER WILLIAM H
Director
90,000$090,000
(Indirect)
View
2022-06-09
Option Award
2022-06-10
4:16 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSRosen Hugh
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:16 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSSimeonidis Simos
Director
90,000$090,000
(Direct)
View
2022-06-09
Option Award
2022-06-10
4:15 pm
N/A
2032-06-09
Regulus Therapeutics Inc.RGLSWitz Pascale
Director
90,000$090,000
(Direct)
View
2022-05-10
Option Award
2022-05-11
4:54 pm
N/A
2030-01-20
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
300,000$0300,000
(Direct)
View
2022-05-10
Option Award
2022-05-11
4:34 pm
N/A
2030-01-20
Regulus Therapeutics Inc.RGLSCALSADA CRISPINA
Chief Financial Officer
50,000$050,000
(Direct)
View
2022-05-10
Option Award
2022-05-11
4:31 pm
N/A
2030-01-20
Regulus Therapeutics Inc.RGLSAker Christopher Ray
Sr. VP & General Counsel
70,000$070,000
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:14 pm
N/A
2032-01-11
Regulus Therapeutics Inc.RGLSDrygin Denis
Chief Scientific Officer
400,000$0400,000
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:13 pm
N/A
2032-01-11
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
1,600,000$02,017,006
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:12 pm
N/A
2032-01-11
Regulus Therapeutics Inc.RGLSCALSADA CRISPINA
Chief Financial Officer
480,000$0480,000
(Direct)
View
2022-01-12
Option Award
2022-01-26
4:11 pm
N/A
2032-01-11
Regulus Therapeutics Inc.RGLSAker Christopher Ray
Sr. VP & General Counsel
480,000$0480,000
(Direct)
View
2021-11-30
Option Award
2021-12-01
4:12 pm
N/A
N/A
Regulus Therapeutics Inc.RGLSPAPADOPOULOS STELIOS
Director
2,222,222$0.365,061,929
(Direct)
View
2021-06-14
Option Award
2021-06-15
5:17 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSSimeonidis Simos
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:46 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSWitz Pascale
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:45 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSRosen Hugh
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:44 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSRASTETTER WILLIAM H
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:43 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSPAPADOPOULOS STELIOS
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:43 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSNunn Jason Raleigh
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:42 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSHuang Alice Shih-hou
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:40 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSCollier Kathryn J
Director
40,000$040,000
(Direct)
View
2021-06-14
Option Award
2021-06-15
4:39 pm
N/A
2031-06-13
Regulus Therapeutics Inc.RGLSBALTIMORE DAVID
Director
40,000$040,000
(Direct)
View
2021-04-14
Conversion
2021-04-16
4:12 pm
N/A
N/A
Regulus Therapeutics Inc.RGLSHagan Joseph P
President and CEO
83,435$0320,478
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, 2, 3, 4, Next